CD14 and Parkinson disease: In CD16+ monocytes, CD14+ CD16+ monocytes, and CD4+ T-cells, RGS10 levels were significantly lower in PD patients compared to HCs (p = 0.043, p = 0.0223, p = 0.0409, respectively) (Fig. 2).